Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

gamestop-(gme)-loses-wall-street-coverage-as-analyst-exits

GameStop (GME) Loses Wall Street Coverage as Analyst Exits

Sep 28, 2025

Key Takeaways: GameStop (GME) is no longer covered by Wedbush, leaving it without a Wall Street rating. The…

Read more
valmont-industries-(vmi):-revisiting-valuation-following-jp.-morgan’s-positive-analyst-coverage-and-growth-catalysts

Valmont Industries (VMI): Revisiting Valuation Following J.P. Morgan’s Positive Analyst Coverage and Growth Catalysts

Sep 28, 2025

Something significant just happened for Valmont Industries (VMI) as shares surged after J.P. Morgan initiated coverage with an…

Read more
new-analyst-coverage-could-be-a-game-changer-for-alliance-resource-partners-(arlp)

New Analyst Coverage Could Be a Game Changer for Alliance Resource Partners (ARLP)

Sep 28, 2025

Texas Capital Securities recently initiated coverage on Alliance Resource Partners, assigning the company a “Buy” rating and expressing…

Read more
cytomx-(ctmx)-shares-surge-on-analyst-coverage-and-drug-potential

CytomX (CTMX) Shares Surge on Analyst Coverage and Drug Potential

Sep 28, 2025

CytomX Therapeutics (CTMX) saw a remarkable stock price increase, surging by 17.84%. The movement was fueled by recent…

Read more
tenet-healthcare-(thc):-evaluating-valuation-after-segment-consolidation-and-upbeat-analyst-coverage

Tenet Healthcare (THC): Evaluating Valuation After Segment Consolidation and Upbeat Analyst Coverage

Sep 27, 2025

Tenet Healthcare (THC) has been grabbing the spotlight lately, thanks to some strategic moves and upbeat analyst commentary.…

Read more
analyst-ratings-usa:-sept-26th,-2025

Analyst Ratings USA: Sept 26th, 2025

Sep 27, 2025

The following are today’s latest 159 analyst ratings tracked from muliple analysts for American listed and traded stocks:…

Read more
why-this-five-star-analyst-sees-21%-upside-in-palo-alto-networks-(panw)-stock

Why This Five-Star Analyst Sees 21% Upside in Palo Alto Networks (PANW) Stock

Sep 27, 2025

Investment firm Tigress Financial Partners has begun coverage of cybersecurity firm Palo Alto Networks (PANW) with a Buy…

Read more
canadian-analyst-coverage-update:-sept-26th,-2025

Canadian Analyst Coverage Update: Sept 26th, 2025

Sep 27, 2025

Analyst Ratings (Canada) The following are today’s latest 24 analyst ratings tracked from muliple analysts for Canadian listed…

Read more
canadian-analyst-coverage-update:-sept-25th,-2025

Canadian Analyst Coverage Update: Sept 25th, 2025

Sep 27, 2025

Analyst Ratings (Canada) The following are today’s latest 29 analyst ratings tracked from muliple analysts for Canadian listed…

Read more
canadian-analyst-coverage-update:-sept-26th,-2025

Canadian Analyst Coverage Update: Sept 26th, 2025

Sep 27, 2025

Analyst Ratings (Canada) The following are today’s latest 24 analyst ratings tracked from muliple analysts for Canadian listed…

Read more
cytomx-(ctmx)-shares-surge-on-analyst-coverage-and-drug-potential

CytomX (CTMX) Shares Surge on Analyst Coverage and Drug Potential

Sep 26, 2025

CytomX Therapeutics (CTMX) saw a remarkable stock price increase, surging by 17.84%. The movement was fueled by recent…

Read more
this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday-–-lyell-immunopharma-(nasdaq:lyel),-first-horizon-(nyse:fhn)

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Lyell Immunopharma (NASDAQ:LYEL), First Horizon (NYSE:FHN)

Sep 26, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 214
  6. 215
  7. 216
  8. 217
  9. 218
  10. 219
  11. 220
  12. ...
  13. 468
  14. »

Posts pagination

Newer posts Page 1 … Page 217 … Page 468 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.